1. Home
  2. RITM vs ALKS Comparison

RITM vs ALKS Comparison

Compare RITM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RITM
  • ALKS
  • Stock Information
  • Founded
  • RITM 2011
  • ALKS 1987
  • Country
  • RITM United States
  • ALKS Ireland
  • Employees
  • RITM N/A
  • ALKS N/A
  • Industry
  • RITM Real Estate Investment Trusts
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RITM Real Estate
  • ALKS Health Care
  • Exchange
  • RITM Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • RITM 6.0B
  • ALKS 5.1B
  • IPO Year
  • RITM N/A
  • ALKS 1991
  • Fundamental
  • Price
  • RITM $11.21
  • ALKS $29.09
  • Analyst Decision
  • RITM Strong Buy
  • ALKS Buy
  • Analyst Count
  • RITM 8
  • ALKS 12
  • Target Price
  • RITM $13.13
  • ALKS $40.00
  • AVG Volume (30 Days)
  • RITM 3.7M
  • ALKS 1.6M
  • Earning Date
  • RITM 07-30-2025
  • ALKS 07-23-2025
  • Dividend Yield
  • RITM 8.94%
  • ALKS N/A
  • EPS Growth
  • RITM N/A
  • ALKS N/A
  • EPS
  • RITM 1.19
  • ALKS 2.09
  • Revenue
  • RITM $3,560,550,000.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • RITM N/A
  • ALKS N/A
  • Revenue Next Year
  • RITM $2.64
  • ALKS $4.25
  • P/E Ratio
  • RITM $9.38
  • ALKS $13.92
  • Revenue Growth
  • RITM 10.49
  • ALKS N/A
  • 52 Week Low
  • RITM $9.13
  • ALKS $22.90
  • 52 Week High
  • RITM $12.20
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • RITM 48.90
  • ALKS 38.82
  • Support Level
  • RITM $11.10
  • ALKS $29.26
  • Resistance Level
  • RITM $11.38
  • ALKS $30.52
  • Average True Range (ATR)
  • RITM 0.15
  • ALKS 0.78
  • MACD
  • RITM -0.02
  • ALKS -0.24
  • Stochastic Oscillator
  • RITM 44.68
  • ALKS 4.96

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: